NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation ...

Noninvasive therapy seeks to enhance focus and behavior by gently stimulating a nerve associated with attention and executive ...

The pain message travels along the trigeminal nerve, which is responsible for the feeling in your face and head. The brain ...

Sufferers say the pain caused by the nerve disorder is so debilitating that they can’t smile, laugh or even make eye contact with another person.

Atypical trigeminal neuralgia (ATN) is a chronic pain condition characterized by persistent facial pain that does not respond ...

brain stimulation, and ablation. In March, the company accelerated the anticipated timeline of its 510(k) submission to the FDA for trigeminal nerve ablation to May 2025. The company had ...

NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from ...

Discover why headaches strike one side of your head, from migraines to nerve disorders, and learn the warning signs that ...

“If cleared by the FDA, we believe there is a potential to generate revenues from trigeminal nerve ablation in late ... solutions for EEG recording, brain stimulation and ablation solutions ...